US Bancorp
ORGO icon

US Bancorp’s Organogenesis Holdings ORGO Stock Holding History

US Bancorp’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-76
Closed -$180 – 4301
2026
Q1 		$180 Buy
+76
New +$263 ﹤0.01% 4110
2025
Q2 		– Sell
-33
Closed -$143 – 4278
2025
Q1 		$143 Buy
+33
New +$133 ﹤0.01% 4120
2023
Q2 		– Sell
-100
Closed -$213 – 4093
2023
Q1 		$213 Buy
100
+73
+270% +$180 ﹤0.01% 4018
2022
Q4 		$73 Sell
27
-380
-93% -$1.11K ﹤0.01% 4094
2022
Q3 		$1K Buy
+407
New +$1.84K ﹤0.01% 3990
2022
Q2 		– Sell
-556
Closed -$4K – 4176
2022
Q1 		$4K Buy
+556
New +$4.3K ﹤0.01% 3681

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

US Bancorp's ORGO Position: Q2 2026 in Review

US Bancorp sold out of Organogenesis Holdings (ORGO) in Q2 2026, closing a stake of 76 shares — an estimated $180 sold.

US Bancorp first reported a position in ORGO in Q1 2022 and held it in 6 quarters. The position peaked at $4K in Q1 2022. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • US Bancorp reported no remaining Organogenesis Holdings position as of Q2 2026 after selling out during the quarter.
  • US Bancorp sold 76 Organogenesis Holdings shares in Q2 2026, an estimated $180.
  • US Bancorp first reported a position in Organogenesis Holdings in Q1 2022 and held it in 6 quarters.
  • US Bancorp's Organogenesis Holdings position peaked at $4K in Q1 2022.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.